1866 related articles for article (PubMed ID: 29049113)
1. The US Opioid Crisis: Current Federal and State Legal Issues.
Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
[TBL] [Abstract][Full Text] [Related]
2. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
[TBL] [Abstract][Full Text] [Related]
3. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
4. Opioids with abuse-deterrent properties: A regulatory and technological overview.
Haddox JD
J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
[TBL] [Abstract][Full Text] [Related]
5. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
[TBL] [Abstract][Full Text] [Related]
6. The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response.
Kanouse AB; Compton P
J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):102-14. PubMed ID: 26095479
[TBL] [Abstract][Full Text] [Related]
7. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
8. Recent developments toward the safer use of opioids, with a focus on hydrocodone.
Covvey JR
Res Social Adm Pharm; 2015; 11(6):901-8. PubMed ID: 25769501
[TBL] [Abstract][Full Text] [Related]
9. America's Opioid Epidemic: Supply and Demand Considerations.
Clark DJ; Schumacher MA
Anesth Analg; 2017 Nov; 125(5):1667-1674. PubMed ID: 29049112
[TBL] [Abstract][Full Text] [Related]
10. Prescription drug monitoring program design and function: A qualitative analysis.
Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
[TBL] [Abstract][Full Text] [Related]
11. Zohydro approval by food and drug administration: controversial or frightening?
Manchikanti L; Atluri S; Candido KD; Boswell MV; Simopoulos TT; Grider JS; Falco FJ; Hirsch JA
Pain Physician; 2014; 17(4):E437-50. PubMed ID: 25054396
[TBL] [Abstract][Full Text] [Related]
12. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
13. Government Legislation in Response to the Opioid Epidemic.
Jones MR; Novitch MB; Sarrafpour S; Ehrhardt KP; Scott BB; Orhurhu V; Viswanath O; Kaye AD; Gill J; Simopoulos TT
Curr Pain Headache Rep; 2019 May; 23(6):40. PubMed ID: 31044343
[TBL] [Abstract][Full Text] [Related]
14. Systematic Literature Review of Prescription Drug Monitoring Programs.
Ponnapalli A; Grando A; Murcko A; Wertheim P
AMIA Annu Symp Proc; 2018; 2018():1478-1487. PubMed ID: 30815193
[TBL] [Abstract][Full Text] [Related]
15. Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing.
McGinty EE; Stuart EA; Caleb Alexander G; Barry CL; Bicket MC; Rutkow L
Implement Sci; 2018 Feb; 13(1):37. PubMed ID: 29482599
[TBL] [Abstract][Full Text] [Related]
16. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems.
Cobaugh DJ; Gainor C; Gaston CL; Kwong TC; Magnani B; McPherson ML; Painter JT; Krenzelok EP
Am J Health Syst Pharm; 2014 Sep; 71(18):1539-54. PubMed ID: 25174015
[TBL] [Abstract][Full Text] [Related]
17. Physician Autonomy and the Opioid Crisis.
Guevremont N; Barnes M; Haupt CE
J Law Med Ethics; 2018 Jun; 46(2):203-219. PubMed ID: 30146981
[TBL] [Abstract][Full Text] [Related]
18. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons.
Weisberg DF; Becker WC; Fiellin DA; Stannard C
Int J Drug Policy; 2014 Nov; 25(6):1124-30. PubMed ID: 25190034
[TBL] [Abstract][Full Text] [Related]
19. How States Are Tackling the Opioid Crisis.
Wickramatilake S; Zur J; Mulvaney-Day N; Klimo MC; Selmi E; Harwood H
Public Health Rep; 2017; 132(2):171-179. PubMed ID: 28152337
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
